Clinical Trial Update: Phase 1 Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of nalbuphine hydrochloride extended-release tablets in adults undergoing hemodialysis f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremic Pruritus

Drugs mentioned

• Nalbuphine HCl ER Tablets (nalbuphine hydrochloride extended-release)

Snippet

Sponsor: Trevi Therapeutics | Conditions: Uremic Pruritus | Phase 1 | Status: COMPLETED